跳至主要内容
临床试验/NCT04859868
NCT04859868已完成不适用

Non-pharmaceutical Motion Sickness Mitigation

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 29 人开始时间: 2021年3月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
29
试验地点
2
主要终点
Motion Perception

研究概览

简要总结

The purpose of this study is evaluate the effect of timing and magnitude on the administration of our nonpharmaceutical treatment to motion sickness, and to evaluate the effect of Galvanic Vestibular Stimulation (GVR) amplitude on functional fitness task performance.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
None

入排标准

年龄范围
21 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Must be able to consent to participate themselves.
  • Must be able to attend in-person sessions at the Mayo Aerospace Medicine and Vestibular Research Laboratory in Scottsdale, AZ.
  • No racial ethnic groups will be excluded.
  • Must be fluent speakers of English.

排除标准

  • History of vestibular disease, migraine, or significant balance disorder.
  • Traumatic brain injury.
  • Recent middle ear infection or recent motion sickness (within 72 hours).
  • History of severe motion sensitivity.
  • Women who are pregnant.

结局指标

主要结局

Motion Perception

时间窗: During the rotation of the chair, approximately 1 hr

Motion Perception verbal report using a visual analog scale (1-100) will be recorded during the rotation of the chair (1=feeling no motion perception; 100=feeling the maximum motion perception)

次要结局

  • Motion Sickness Questionnaire(During the rotation of the chair, approximately 1 hr)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gaurav N. Pradhan

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验